Pyott David E I
CIK 0001051578
Director
Filings
19
Latest Jun 3, 2026
Issuers covered
4
Showing
19 of 19
Page 1
Track record
4 of 9 open-market trades scored (44% price coverage) - 5 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 4 | 25% | -0.4% | -6.1% | +16.8% | -6.1% |
| 90 days | 4 | 0% | -18.4% | -22.0% | -7.7% | -22.0% |
| 180 days | 4 | 0% | -21.0% | -8.7% | -8.7% | -57.9% |
| 365 days | 4 | 0% | -35.8% | -45.8% | -6.0% | -45.8% |
Issuers
Companies where Pyott David E I has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals, Inc. | 10 | Jun 3, 2026 |
| PLRX | Pliant Therapeutics, Inc. | 4 | Jun 9, 2025 |
| BMRN | Biomarin Pharmaceutical Inc | 3 | May 23, 2024 |
| TARS | Tarsus Pharmaceuticals, Inc. | 2 | Apr 28, 2026 |
All filings
19 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|